Therefore, even in the presence of higher PGC-1α gene expression as a result of mTOR hyperactivity during early AMD stages, a reduction in PGC-1α activity in later stages could ultimately affect mitochondrial turnover and biogenesis causing increased ROS production and cell death. This evidence concerns the gene PPARGC1A and age-related macular degeneration.